These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7589201)

  • 21. Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester.
    Boja JW; Cadet JL; Kopajtic TA; Lever J; Seltzman HH; Wyrick CD; Lewin AH; Abraham P; Carroll FI
    Mol Pharmacol; 1995 Apr; 47(4):779-86. PubMed ID: 7723739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.
    Volkow ND; Wang GJ; Fowler JS; Fischman M; Foltin R; Abumrad NN; Gatley SJ; Logan J; Wong C; Gifford A; Ding YS; Hitzemann R; Pappas N
    Life Sci; 1999; 65(1):PL7-12. PubMed ID: 10403500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.
    Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N; Nakanishi S
    Brain Res; 1999 Dec; 849(1-2):85-96. PubMed ID: 10592290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    J Neurosci; 2000 Sep; 20(18):7067-73. PubMed ID: 10995853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography.
    Halldin C; Farde L; Lundkvist C; Ginovart N; Nakashima Y; Karlsson P; Swahn CG
    Synapse; 1996 Apr; 22(4):386-90. PubMed ID: 8867033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
    Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Hitzemann R; Pappas N
    Am J Psychiatry; 1998 Oct; 155(10):1325-31. PubMed ID: 9766762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]WIN 35,428 binding in the caudate nucleus of the rabbit: evidence for a single site on the dopamine transporter.
    Aloyo VJ; Ruffin JS; Pazdalski PS; Kirifides AL; Harvey JA
    J Pharmacol Exp Ther; 1995 Apr; 273(1):435-44. PubMed ID: 7714799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
    Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
    Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
    Scheffel U; Pögün S; Stathis M; Boja JW; Kuhar MJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):954-8. PubMed ID: 2046028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and in vivo specificity of [11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron.
    Ding YS; Fowler JS; Volkow ND; Gatley SJ; Logan J; Dewey SL; Alexoff D; Fazzini E; Wolf AP
    Synapse; 1994 Oct; 18(2):152-60. PubMed ID: 7839313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].
    Fleckenstein AE; Pögün S; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):200-6. PubMed ID: 8858994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-ethylmaleimide irreversibly inhibits the binding of [3H]threo-(+-)-methylphenidate to the stimulant recognition site.
    Schweri MM
    Neuropharmacology; 1990 Oct; 29(10):901-8. PubMed ID: 2255384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine transporters decrease with age.
    Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Hitzemann R; Smith G; Fields SD; Gur R
    J Nucl Med; 1996 Apr; 37(4):554-9. PubMed ID: 8691238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET.
    Fischer K; Sossi V; von Ameln-Mayerhofer A; Reischl G; Pichler BJ
    Neuroimage; 2012 Feb; 59(3):2413-22. PubMed ID: 21945469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding.
    Reith ME; Xu C; Coffey LL
    Biochem Pharmacol; 1996 Nov; 52(9):1435-46. PubMed ID: 8937455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high".
    Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Dewey SL; Hitzemann R; Gifford AN; Pappas NR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):14-20. PubMed ID: 9862747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo binding of [125I]RTI-55 to dopamine transporters: pharmacology and regional distribution with autoradiography.
    Cline EJ; Scheffel U; Boja JW; Mitchell WM; Carroll FI; Abraham P; Lewin AH; Kuhar MJ
    Synapse; 1992 Sep; 12(1):37-46. PubMed ID: 1411962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?
    Xu C; Reith ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1340-8. PubMed ID: 8819521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.